Healius in management shake-up after CEO exit
Simon EvansSenior reporter
Embattled pathology group Healius has stepped up internal restructuring and cost-cutting in a push to lift its financial performance as investment bankers UBS oversee a strategic review.
Two top executives in the group’s Queensland pathology business QML have departed in the restructure outlined in an internal email on March 27 from the boss of the Healius Pathology division, Jan Van Rooyen.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles